Vladimir Khristenko, President of NANOLEK and Maxim Stetsyuk, executive director of the company, were included for the second year in a row in the TOP list of best managers in Russia, the Russian Association of Managers.

The TOP list consist of leaders from different business areas, who, through their achievements, have proved not only their professional reputation but also their ability to meet the current challenges. The primary principle taken as a basis of the ranking for many years is as follows: “The best sel ect the best.” The experts are all the finalists of the past years’ award and the current members of the Association of Managers (more than 150 participants). The list is annually updated by approximately 40-50%. This year, this figure has not been exceeded, which indicates the stability of business to a turbulent external environment.

Maxim Stetsyuk, Executive Director of NANOLEK:

“NANOLEK is practically the youngest pharmaceutical company. We are only nine years old, and we have been in this list for two years now. I congratulate all my colleagues from the pharmaceutical industry on adding to the list. It is especially important to note that our work was acknowledged in this year as activities of pharmaceutical companies grab the headlines in these challenging times. I wish you good luck and, of course, new interesting projects. I want to say a huge ‘thank you’ to the entire NANOLEK team. Membership in the “TOP-1000” list resulted fr om well-coordinated everyday work. I am sure that there are still many successes ahead as we have great potential. Dear colleagues, you are the best!”

THE COMPANY’S ACHIEVEMENTS are THE BEST proof of THE DIRECTOR’S statement

In 2020, NANOLEK was included in the list of systemic companies of the Russian economy. The decision to add the organization to the list was made by the government commission to improve the sustainability of the Russian economy’s development. The industry list was posted on the website of the Ministry of Industry and Trade of Russia on April 25, 2020.

Besides, NANOLEK became the winner of the Platinum Ounce Award in the Vector of the Year nomination, sub-nomination “Project of the Year. Business Project” and received an award for establishment of a small investment company - Invac - jointly with the Chumakov Scientific Center, which will produce full-cycle vaccines to immunize the Russian citizens according to the National Vaccination Schedule. The first project of MIP Invac was the production of a fully domestic polio vaccine, which was submitted for registration in April 2020. As soon as vaccine is released for production, we will be able to uninterruptedly supply a highly efficient and safe vaccine included in the list of the National Vaccination Schedule to the citizens of the Russian Federation.

In early September, NANOLEK was added to the first Forbes ranking “The Best Russian Pharmaceutical Companies”.

All these achievements became possible thanks to the well-coordinated work of both the Moscow office and the biopharmaceutical production in the Kirov Region, which, even during the pandemic, did not suspend its operations for a single minute.

Traditionally, the TOP-1000 list is published in the media of the Kommersant publishing house (you can read the full version by clicking on the “Source” button).